Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02182583 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Ba253MDI
DRUG: Ba253BINEB

Sponsor

Boehringer Ingelheim